Clin2
NCT07242443Possibly a fitNot yet recruiting

Tegoprazan and amoxicillin for H. pylori: twice vs three times daily

HELICOBACTER PYLORI INFECTIONS

Treatments studied

Part of Digestive system clinical trials.

This trial tests whether taking two drugs (tegoprazan and amoxicillin) twice a day works as well as taking them three times a day to clear an H. pylori infection in the stomach. The goal is to find a simpler, easier schedule that still works.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
240 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You are between 18 and 70 years old.
  • You have a confirmed H. pylori infection (testing for the bacteria in your stomach by a breath test, stool test, or stomach biopsy).
  • You are willing to take the study drugs and come back for a follow-up test 4 to 8 weeks after treatment.
  • You are not allergic to tegoprazan, amoxicillin, or any penicillin-like antibiotics.
  • You have not used antibiotics, acid-reducing drugs (like omeprazole or pantoprazole), bismuth (like Pepto-Bismol), or other stomach-acid blockers in the last 4 weeks.
  • You do not have severe liver or kidney problems, and you are not pregnant or breastfeeding.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06723197Recruiting· Phase 4
Comparing treatment lengths for H. pylori infection

This trial compares different lengths of treatment with two or four medications to see which works best for clearing H. pylori, a stomach bacteria that can cause ulcers. It is for people who have not been treated for this infection before.

Jinan, Shandong
NCT07179159Recruiting
14-day stomach infection treatment study

This study compares two treatments for an H. pylori stomach infection: taking two medicines (vonoprazan and amoxicillin) versus taking four medicines. Both treatments are given for 14 days.

Jinan, Shandong
NCT07275827Not yet recruiting· Phase 3
Testing 3 treatments for H. pylori infection

This study compares two different acid-reducing medications, given with or without zinc, to see which is safer and works best for treating H. pylori. All treatments are combined with two antibiotics.

Shibīn al Kawm
NCT07750938Not yet recruiting· Phase 4
Optimized treatment for H. pylori infection with stronger acid control

This study tests a new combination of medicines to treat H. pylori, a common stomach infection that can cause ulcers. The goal is to see if a stronger acid-reducing approach helps the treatment work better.

NCT07242456Recruiting· Phase 2/Phase 3
Comparing two treatments for H. pylori infection

This study tests two different combinations of medications to treat H. pylori, a stomach bacteria that can cause ulcers. You would take one of the two combinations for a short time to see which works better at getting rid of the infection.

Hangzhou, Zhejiang
NCT06929962Recruiting· Phase 4
VA dual sequential therapy for H. pylori gastritis

This trial tests a new two-step antibiotic treatment for adults with chronic gastritis caused by H. pylori bacteria. If you have not been treated for H. pylori before and are between 18 and 70, you may be able to join.

Nanjing, Jiangsu

Hear when a new HELICOBACTER PYLORI INFECTIONS trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.